OMNICELL, INC. (OMCL)
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
Address
4220 NORTH FREEWAY
FORT WORTH, TX 76137
Founded
1992
Number of Employees
3,650
Website
http://www.omnicell.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
$4,064 | - | - | - | - | - | $53,035 | - | $52,209 | - | - | $36,436 |
| Average Price | $27.88 | - | - | - | - | - | $70.78 | - | $134.11 | - | - | $85.11 |
| # Shares Purchased | 145,737 | - | - | - | - | - | 749,300 | - | 389,300 | - | - | 428,112 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | 54.2% | - | - | - | - | - | -39.2% | - | -67.9% | - | - | -49.5% |
| S&P 500 Return to Date | 181.9% | - | - | - | - | - | 74.8% | - | 37.3% | - | - | 98.0% |
| Excess Total Return | -127.7% | - | - | - | - | - | -114.1% | - | -105.2% | - | - | -147.5% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | 48% | - | - | - | - | - | 11% | - | 6% | - | - | 14% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at OMCL make a trade.
Creating a free account takes less than one minute